Optimizing Frontline Therapy Selection and Follow-Up in CLL

preview_player
Показать описание
Given an increasingly complex frontline setting, experts consider optimal therapy selection and follow-up for patients with chronic lymphocytic leukemia.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Optimizing Frontline Therapy 0:08:16

Optimizing Frontline Therapy Selection and Follow-Up in CLL

Optimizing Frontline Therapy 0:05:41

Optimizing Frontline Therapy and Maintenance in FL

Frontline Therapy for 0:04:16

Frontline Therapy for HCC: Optimizing Treatment Selection

Selecting the Optimal 0:04:20

Selecting the Optimal Frontline Therapy in CLL

Enhancing Clinical Outcomes 0:25:12

Enhancing Clinical Outcomes in CLL through Selection of Optimal Frontline Therapy

EGFR-Mutant NSCLC: Optimizing 0:03:55

EGFR-Mutant NSCLC: Optimizing Therapy Selection

Dr. Kahl on 0:01:35

Dr. Kahl on Frontline Therapy Selection in CLL

Optimizing initial therapy 0:01:15

Optimizing initial therapy of CLL

Optimizing Treatment Pathways 0:36:55

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

Optimizing the Upfront 0:08:43

Optimizing the Upfront Treatment of Metastatic Renal Cell Carcinoma

Optimizing Therapeutic Approaches 0:05:02

Optimizing Therapeutic Approaches to MCL

EHA 2024 Recap: 0:37:22

EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway

Frontline Fixed-Duration Therapy 0:06:31

Frontline Fixed-Duration Therapy in CLL: Improving Outcomes and Tolerability

HCC Management With 1:32:51

HCC Management With Your Multidisciplinary Team: Effective Selection and Sequencing Strategies

Optimizing Frontline Chemotherapy 0:06:59

Optimizing Frontline Chemotherapy in Metastatic Colorectal Cancer

Selecting and Optimizing 0:15:48

Selecting and Optimizing Treatment Strategies in Patients with Metastatic Colorectal Cancer: Q&A

Optimizing Nursing Strategies 1:06:24

Optimizing Nursing Strategies in Personalized Bladder Cancer Care

Rebooting the BTK 0:59:49

Rebooting the BTK Inhibitor Sequence in MCL

Metastatic Colorectal Cancer: 0:28:29

Metastatic Colorectal Cancer: Optimizing Dosing Strategy for Late-Line Therapies

Optimizing the Use 0:03:16

Optimizing the Use of Ipilimumab/Nivolumab in mRCC

Optimizing Treatment Strategies 0:04:26

Optimizing Treatment Strategies for Patients With CLL

Dr. Kahl on 0:01:53

Dr. Kahl on Frontline BTK Inhibitor Selection in CLL

Optimizing elderly MM 0:01:13

Optimizing elderly MM patient treatment

Frontline Treatment of 0:03:30

Frontline Treatment of Advanced NSCLC